Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylethanolamine binding protein 1 pseudogene 1 (PEBP1P1) is a non-coding genomic sequence classified as a pseudogene. It is related to the protein-coding PEBP1 gene, which encodes a multifunctional modulator involved in several signaling pathways and is also known as Raf kinase inhibitory protein (RKIP). Unlike the functional PEBP1 gene, PEBP1P1 does not produce a protein product and has no established biological or therapeutic relevance[1][3]. If you are seeking information on the functional gene, refer to phosphatidylethanolamine binding protein 1 (PEBP1, also known as RKIP), which does have documented biological functions and potential disease associations[1][4]. However, PEBP1P1 is not considered a therapeutic target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylethanolamine binding protein 1 pseudogene 1 (PEBP1P1).